Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2013 Jan 01;84:e61112. doi: 10.1371/journal.pone.0061112.
Show Gene links
Show Anatomy links
A trafficking-deficient mutant of KCC3 reveals dominant-negative effects on K-Cl cotransport function.
Ding J
,
Ponce-Coria J
,
Delpire E
.
???displayArticle.abstract???
The K-Cl cotransporter (KCC) functions in maintaining chloride and volume homeostasis in a variety of cells. In the process of cloning the mouse KCC3 cDNA, we came across a cloning mutation (E289G) that rendered the cotransporter inactive in functional assays in Xenopus laevis oocytes. Through biochemical studies, we demonstrate that the mutant E289G cotransporter is glycosylation-deficient, does not move beyond the endoplasmic reticulum or the early Golgi, and thus fails to reach the plasma membrane. We establish through co-immunoprecipitation experiments that both wild-type and mutant KCC3 with KCC2 results in the formation of hetero-dimers. We further demonstrate that formation of these hetero-dimers prevents the proper trafficking of the cotransporter to the plasma membrane, resulting in a significant decrease in cotransporter function. This effect is due to interaction between the K-Cl cotransporter isoforms, as this was not observed when KCC3-E289G was co-expressed with NKCC1. Our studies also reveal that the glutamic acid residue is essential to K-Cl cotransporter function, as the corresponding mutation in KCC2 also leads to an absence of function. Interestingly, mutation of this conserved glutamic acid residue in the Na(+)-dependent cation-chloride cotransporters had no effect on NKCC1 function in isosmotic conditions, but diminished cotransporter activity under hypertonicity. Together, our data show that the glutamic acid residue (E289) is essential for proper trafficking and function of KCCs and that expression of a non-functional but full-length K-Cl cotransporter might results in dominant-negative effects on other K-Cl cotransporters.
???displayArticle.pubmedLink???
23593405
???displayArticle.pmcLink???PMC3617232 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 2. Co-immunoprecipitation reveals interaction between KCC3 and KCC2.Xenopus laevis oocytes were injected with KCC2 cRNA in the presence or absence of wild-type KCC3 or KCC3-E289G cRNAs. KCC2 or KCC3 were then immunoprecipitated and the complex was analyzed by Western blot analysis using rabbit polyclonal anti-KCC2 or anti-KCC3 antibodies. Immunodetection of KCC2, KCC3 and IgG are indicated on the right of the panels. Note that both KCC2 (panel A) and KCC3 (panel B) when immunoprecipitated are observed as 2 bands: unglycosylated and glycosylated forms. Experiment was repeated once and yielded similar data.
Figure 3. Evidence for dominant-negative effect of KCC3 on KCC2 function.A) Xenopus laevis oocytes were injected with KCC2 cRNA in the presence or absence of wild-type KCC3 or KCC3-E289G cRNAs. Three days following injection, K+ influx was measured under isosmotic conditions where only KCC2 function is active, or under hyposmotic conditions where both KCC2 and KCC3 function are stimulated. Bars represent mean ± S.E.M. (nâ=â20â25 oocytes). Flux is expressed in nmoles K+/oocyte/h. (*) P<0.01 (ANOVA) compared with KCC2 alone under isosmotic condition, (â) P<0.01 (ANOVA) compared with KCC2 alone under hyposmotic solution. Arrow indicates the anticipated flux mediated by the combined activity of KCC2 and KCC3. This is a representative experiment. Each condition (bar) was reproduced multiple times. B) K+ influx was measured under hyperosmotic conditions in oocytes injected with NKCC1 cRNA in the presence or absence of KCC3-E289G cRNA. Bars represent mean ± S.E.M. (nâ=â20â25 oocytes). Flux is also expressed in nmoles K+/oocyte/h.
Figure 4. Evidence for dominant-negative effect of KCC3 on KCC2 trafficking.Xenopus laevis oocytes were injected with KCC2 in the presence or absence of wild-type KCC3 or KCC3-E289G cRNAs and membrane fractions were isolated using a silica cross-linking method. Membrane proteins and whole oocyte lysates were subjected to Western blot analysis using rabbit polyclonal anti-KCC2 or anti-KCC3 antibodies. Experiment was reproduced 3 times.
Figure 5. Evidence for dominant-negative effect of KCC3 on KCC2 trafficking and function.Xenopus laevis oocytes were injected with KCC3, KCC3-E289G, or both. A) Membrane fraction was isolated using a silica based cross-linking method and membrane proteins and whole oocyte lysates were subjected to Western blot analysis using rabbit polyclonal anti-KCC2 or anti-KCC3 antibodies. B) K+ influx was measured under hyposmotic conditions. C) K+ influx generated by KCC3-KCC3 and KCC3-KCC3-E289G concatamers. Bars represent mean ± S.E.M. (nâ=â20â25 oocytes). Flux is expressed in nmoles K+/oocyte/h. *P<0.001 (ANOVA) compared with KCC3 controls. Experiment was performed 6 times with similar data.
Figure 6. N-Glycolsylation deficiency of the KCC3-E289G mutant.A) Western blot analyses of KCC3-E289G mutant in HEK 293FT cells and Xenopus laevis oocytes compared to wild-type KCC3 in HEK 293FT cells, wild-type and mutant CHO cells, and Xenopus laevis oocytes, using rabbit polyclonal anti-KCC3 antibody. CHO-Lec1 cells have mutation in N-acetylglucosaminyl transferase, whereas CHO-Lec8 and CHO-Lec2 have deficient galactose and sialic acid transporters, respectively. Two independent experiments are shown. Experiment was performed 4 times. B) Scheme represents the main steps in N-linked oligosaccharide biosynthetic pathway. First, core Glc-Nac-Glc-Nac-Man with branched mannose residues are added to the Asparagines in the ER. In the Golgi, mannose molecules are replaced by acethylglucosamyl groups, followed by the addition of galactose and sialic acid groups. These steps require the availability of galactose and sialic acid in the cells, which is prevented in the mutant CHO cells by elimination of specific transporters.
Figure 7. N-Glycolsylation deficiency of the KCC3-E289G mutant.A) Western blot analysis of wild-type KCC3 and KCC3-E289G mutant in HEK 293FT cells treated with tunicamycin (10 µg/ml for 18 h). B) Western blot analysis of wild-type KCC3 and KCC3-E289G mutant proteins isolated from Xenopus laevis oocytes and treated with PNGase (0.25U, 12 h at 37°C). The membranes were exposed to a rabbit polyclonal anti-KCC3 antibody. The experiment was repeated once with identical data.
Figure 8. Evidence for KCC3-E289G localizing in the endoplasmic reticulum.HEK 293FT cells were transfected with wild-type KCC3 (AâF) or KCC3-E289G mutant (GâL). Two days post- transfection, the cells were fixed with paraformaldehyde, treated with saponin, and exposed to rabbit polyclonal anti-KCC3 and mouse monoclonal anti-PDI antibodies followed by cy3-conjugated anti-rabbit and Alexa Fluorâconjugated goat anti-mouse antibodies. Focal plane images of KCC3 signal (A, D, J, G), ER marker signal (B, E, H, K), and combined signals (C, F, I, L). Barâ=â5 µm.
Figure 9. Sub-cellular localization of KCC3 and KCC3-E289G in HEK 293FT cells.HEK 293FT cells were transfected with wild-type KCC3 or KCC3-E289G mutant. Two days post-transfection, the cells were treated with digitonin to extract proteins from cholesterol-rich (plasma) membranes (membrane/cytosol fraction), followed by NP40 treatment to isolate proteins from ER/Golgi fraction, followed by deoxycholate+SDS detergents to isolate proteins from nuclear fraction. Western blots were probed with rabbit polyclonal anti-KCC3 and mouse monoclonal anti-PDI and anti-GAPDH antibodies. Experiment was reproduced at least 5 times with similar data.
Figure 10. Effect of E289G-like mutations in KCC2 and NKCC1.K+ influx was measured through unidirectional 86Rb tracer uptake in oocytes injected with water, wild-type KCC2 or KCC2-E201G or KCC2-E201D mutant cRNAs, and wild-type or NKCC1-E383G or NKCC1-E383D mutant cRNAs. Uptakes were measured under isosmotic (200 mOsM) and hypotonic (100 mOsM) solutions for KCC2 and under isotonic and hypertonic (265 mOsM) solutions for NKCC1. Bars represent means±SEM (nâ=â20â25 oocytes). Fluxes are expressed in nmoles K+/oocyte/h. (*) Denotes statistical significance with P<0.001 (ANOVA followed by Tukey-Kramer Multiple Comparisons Test). Experiment was done once.
Figure 1. Absence of function of KCC3-E289G mutant cDNA.A) Conservation of glutamic acid residue (E289 in mouse KCC3) within mouse SLC12A cotransporters. The residue, highlighted by an arrowhead in cartoon and sequence alignment, is localized at the end or right downstream of transmembrane domain 3 (TM3). B) K+ influx was measured through unidirectional 86Rb tracer uptake under isosmotic and hyposmotic conditions, in oocytes injected with water, KCC3-E289G mutant cRNA, and wild-type KCC3 cRNA. Bars represent means±SEM (nâ=â25 oocytes).
Adragna,
Hypertension in K-Cl cotransporter-3 knockout mice.
2004, Pubmed
Adragna,
Hypertension in K-Cl cotransporter-3 knockout mice.
2004,
Pubmed
Belenky,
Cell-type specific distribution of chloride transporters in the rat suprachiasmatic nucleus.
2010,
Pubmed
Blaesse,
Cation-chloride cotransporters and neuronal function.
2009,
Pubmed
Boettger,
Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold.
2003,
Pubmed
Byun,
Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice.
2007,
Pubmed
Casula,
A dominant negative mutant of the KCC1 K-Cl cotransporter: both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity.
2001,
Pubmed
,
Xenbase
Chen,
The emerging role of KCl cotransport in tumor biology.
2010,
Pubmed
Crable,
Multiple isoforms of the KC1 cotransporter are expressed in sickle and normal erythroid cells.
2005,
Pubmed
Delpire,
Housing and husbandry of Xenopus laevis affect the quality of oocytes for heterologous expression studies.
2011,
Pubmed
,
Xenbase
Delpire,
Cation-Chloride Cotransporters in Neuronal Communication.
2000,
Pubmed
Di Fulvio,
Protein kinase G regulates potassium chloride cotransporter-4 [corrected] expression in primary cultures of rat vascular smooth muscle cells.
2001,
Pubmed
Filteau,
Corpus callosum agenesis and psychosis in Andermann syndrome.
1991,
Pubmed
Gagnon,
Characterization of glial cell K-Cl cotransport.
2007,
Pubmed
Gagnon,
Functional insights into the activation mechanism of Ste20-related kinases.
2011,
Pubmed
,
Xenbase
Gagnon,
Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.
2012,
Pubmed
Gagnon,
Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts.
2013,
Pubmed
Gagnon,
Molecular determinants of hyperosmotically activated NKCC1-mediated K+/K+ exchange.
2010,
Pubmed
,
Xenbase
Garzón-Muvdi,
WNK4 kinase is a negative regulator of K+-Cl- cotransporters.
2007,
Pubmed
,
Xenbase
Hebert,
Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family.
2004,
Pubmed
Hoffmann,
Physiology of cell volume regulation in vertebrates.
2009,
Pubmed
Holden,
Crude subcellular fractionation of cultured mammalian cell lines.
2009,
Pubmed
Howard,
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum.
2002,
Pubmed
,
Xenbase
Jennings,
Okadaic acid inhibition of KCl cotransport. Evidence that protein dephosphorylation is necessary for activation of transport by either cell swelling or N-ethylmaleimide.
1991,
Pubmed
Kahle,
Roles of the cation-chloride cotransporters in neurological disease.
2008,
Pubmed
Kahle,
Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases.
2010,
Pubmed
Larbrisseau,
The Andermann syndrome: agenesis of the corpus callosum associated with mental retardation and progressive sensorimotor neuronopathy.
1984,
Pubmed
Lauf,
Regulation of potassium transport in human lens epithelial cells.
2006,
Pubmed
Lauf,
Erythrocyte K-Cl cotransport: properties and regulation.
1992,
Pubmed
Leduc-Nadeau,
Elaboration of a novel technique for purification of plasma membranes from Xenopus laevis oocytes.
2007,
Pubmed
,
Xenbase
Le Rouzic,
KCC3 and KCC4 expression in rat adult forebrain.
2006,
Pubmed
Mercier-Zuber,
Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.
2011,
Pubmed
Pacheco-Alvarez,
WNK3-SPAK interaction is required for the modulation of NCC and other members of the SLC12 family.
2012,
Pubmed
,
Xenbase
Pacheco-Alvarez,
WNK3 is a putative chloride-sensing kinase.
2011,
Pubmed
,
Xenbase
Pearson,
Localization of the K(+)-Cl(-) cotransporter, KCC3, in the central and peripheral nervous systems: expression in the choroid plexus, large neurons and white matter tracts.
2001,
Pubmed
Rubenstein,
In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
1997,
Pubmed
Rust,
Neurogenic mechanisms contribute to hypertension in mice with disruption of the K-Cl cotransporter KCC3.
2006,
Pubmed
Salin-Cantegrel,
Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosum.
2011,
Pubmed
,
Xenbase
Shekarabi,
Loss of neuronal potassium/chloride cotransporter 3 (KCC3) is responsible for the degenerative phenotype in a conditional mouse model of hereditary motor and sensory neuropathy associated with agenesis of the corpus callosum.
2012,
Pubmed
Shekarabi,
Cellular expression of the K+-Cl- cotransporter KCC3 in the central nervous system of mouse.
2011,
Pubmed
Simard,
Homooligomeric and heterooligomeric associations between K+-Cl- cotransporter isoforms and between K+-Cl- and Na+-K+-Cl- cotransporters.
2007,
Pubmed
,
Xenbase
Zeitlin,
Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate.
2002,
Pubmed